Literature DB >> 10582233

Increases in the threshold for the development of epileptiform activity in field CA1 of Krushinskii-Molodnika rat hippocampal slices as an adaptive protective mechanism.

A V Sem'yanov1, E D Morenkov, S V Kalemenev, V P Yaroshenko, O V Godukhin.   

Abstract

Studies were carried out into the chances of developing epileptiform activity in the neuronal network of hippocampal field CA1 in normal (Wistar) rats and in rats genetically predisposed to audiogenic convulsions (Krushinskii-Molodkina rats). The development of epileptiform activity was assessed in terms of the reduction in the threshold for development trains of epileptiform discharges in field CA1 of hippocampal slices, which were induced using episodic increases in the extracellular K+ concentration ([K+]0) or decreases in the extracellular Mg2+ concentration ([Mg2+]0). These experiments showed that the threshold for the development of trains of epileptiform discharges increased in field CA1 of hippocampal slices of Krushinskii-Molodkina rats, while the excitability of glutamatergic Schaffer collaterals/commissural fibers was decreased. In addition, Krushinskii-Molodkina rats showed no long-term potentiation of glutamatergic synaptic transmission or potentiation of the EPSP-spike system in pyramidal neurons, induced in field CA1 of hippocampal slices in Wistar rats by reductions in [Mg2+]0 and increases in [K+]0 respectively. It is suggested that this underlies the operation of an adaptive protective mechanism preventing the propagation of convulsive activity in the Krushinskii-Molodkina rat brain.

Entities:  

Mesh:

Year:  1999        PMID: 10582233     DOI: 10.1007/BF02461087

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  12 in total

1.  The decreased susceptibility to the development of in vitro kindling-like state in hippocampal CA1 slices of rats sensitive to audiogenic seizures.

Authors:  A Semyanov; E Morenkov; O Godukhin
Journal:  Neurosci Lett       Date:  1997-07-25       Impact factor: 3.046

2.  The dentate gyrus as a regulated gate for the propagation of epileptiform activity.

Authors:  U Heinemann; H Beck; J P Dreier; E Ficker; J Stabel; C L Zhang
Journal:  Epilepsy Res Suppl       Date:  1992

3.  NMDA receptor complex and kindling mechanisms.

Authors:  K Morimoto; M Sato
Journal:  Epilepsy Res Suppl       Date:  1992

4.  Kindling increases brain levels of NAAG and seizures reduce activity of a NAAG-hydrolyzing enzyme, NAALADase.

Authors:  J L Meyerhoff; M B Robinson; K J Koller; M A Bixler; J T Coyle
Journal:  Epilepsy Res Suppl       Date:  1992

5.  Kindling-like state in rat hippocampal CA1 slices induced by the repeated short-term extracellular K+ increases: the role of L-type Ca(2+)-channels.

Authors:  A Semyanov; O Godukhin
Journal:  Neurosci Lett       Date:  1997-02-28       Impact factor: 3.046

6.  Calcium currents in pyramidal CA1 neurons in vitro after kindling epileptogenesis in the hippocampus of the rat.

Authors:  G C Faas; M Vreugdenhil; W J Wadman
Journal:  Neuroscience       Date:  1996-11       Impact factor: 3.590

7.  Closely spaced recurrent hippocampal seizures elicit two types of heightened epileptogenesis: a rapidly developing, transient kindling and a slowly developing, enduring kindling.

Authors:  E W Lothman; J M Williamson
Journal:  Brain Res       Date:  1994-06-27       Impact factor: 3.252

8.  A permanent change in brain function resulting from daily electrical stimulation.

Authors:  G V Goddard; D C McIntyre; C K Leech
Journal:  Exp Neurol       Date:  1969-11       Impact factor: 5.330

9.  Interictal cerebral metabolic levels in Wistar rats sensitive to audiogenic seizures.

Authors:  A Nehlig; A Pereira de Vasconcelos; M Vergnes; S Boyet; C Marescaux
Journal:  Brain Res       Date:  1996-06-10       Impact factor: 3.252

10.  A genetic, physiological, and biochemical investigation of audiogenic seizures in rats.

Authors:  L G Romanova; Z A Zorina; L I Korochkin
Journal:  Behav Genet       Date:  1993-09       Impact factor: 2.805

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.